Toggle navigation
TWunroll
TWunroll
faq
Contact US
Matthew Herper
matthewherper
$REGN CSO George Yancopoulos presented more detail over the weekend on the company's data for the company's monoclonal antibody cocktail Covid-19 in patients who are not yet hospitalized.A quick thread.
Read more
This morning, we're releasing a look at all the clinical trials against #COVID19. One big conclusion: we've spent a lot of resources on #Hydroxychloroquine, probably too much.https://www.statnews.com/2020/07/06/data-show-panic-and-d
Read more
So, contrary to things I'm seeing on Twitter, $GILD has NOT shown a mortality benefit for remdesivir this morning. It's suggested one, and that's very different.PR: https://www.gilead.com/news-and-press/press-room/press-releases
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree